Thrombolytic therapy for acute ischemic stroke: the likelihood of being helped versus harmed.
Demaerschalk
Bart M
BM
D000208:Acute Disease / Q000628:therapy; D002545:Brain Ischemia / Q000188:drug therapy*; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000401:mortality / Q000517:prevention & control; D002985:Clinical Protocols / Q000592:standards; D004632:Emergency Medical Services / Q000592:standards / Q000706:statistics & numerical data; D006801:Humans; D007258:Informed Consent / Q000592:standards; D018570:Risk Assessment; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000009:adverse effects* / Q000592:standards* / Q000706:statistics & numerical data; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*; D016896:Treatment Outcome
D010959:Tissue Plasminogen Activator